FDA Drug Application (021226) for KALETRA by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number021226
Product Number001
FormCAPSULE;ORAL
Dosage133.3MG;33.3MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameKALETRA
Active IngredientLOPINAVIR; RITONAVIR

Active IngredientCount
List of drugs with Active Ingredient LOPINAVIR3
List of drugs with Active Ingredient RITONAVIR11


Back to FDA Applications sponsored by ABBVIE